Abbott Receives CE Mark For FlexNav TAVR System

Abbott enters the highly competitive TAVR market with its newly CE-marked FlexNav delivery system for Portico.

Transcatheter aortic valve replacement implantation TAVR TAVI minimally invasive surgery for treatment Aortic stenosis AS

Abbott Laboratories Inc. announced it has received a CE mark for its FlexNav delivery device for the Portico transcatheter aortic valve replacement (TAVR) system for patients at high or extreme risk for open heart surgery.

Abbott said the FlexNav system offers physicians improved delivery, flexibility and navigation during implant, even in complex cardiac anatomies.

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Approvals

More from Policy & Regulation